No suprises in store from GlaxoSmithKline, say analysts
Analysts are expecting few surprises when GlaxoSmithKline reveals its first quarter results tomorrow.
They said teething problems arising from the merger of Glaxo Wellcome and SmithKline Beecham will have been ironed out, creating a positive performance.